Loading paragraph...
Today's Biggest Stock Gainers
| Symbol | Name | Last Price | Change | % Change | Volume | Market Cap | 52-Week Range |
|---|---|---|---|---|---|---|---|
| ANGH | Anghami | $3.88 | $1.56 | 67.03% | 37.2M | $16M | $2.25$8.40 |
| ESHA | Esh Acquisition Corp. | $22.43 | $8.05 | 56.01% | 6.1M | $56M | $10.76$27.00 |
| SIDU | Sidus Space | $3.61 | $0.94 | 35.12% | 79.1M | $94M | $0.63$3.74 |
| VNDA | Vanda Pharmaceuticals | $9.14 | $2.11 | 30.01% | 17.3M | $415M | $3.81$9.60 |
| ULY | Urgent.ly | $3.35 | $0.59 | 21.20% | 11.3M | $6.0M | $1.74$17.99 |
| BCG | Binah Capital Group | $3.19 | $0.53 | 19.93% | 34K | $44M | $1.36$5.81 |
| AXSM | Axsome Therapeutics | $177.60 | $28.81 | 19.36% | 1.6M | $7.5B | $79.19$178.99 |
| BENF | Beneficient | $6.80 | $1.04 | 18.06% | 148.3K | $81M | $1.75$12.48 |
| PODC | PodcastOne | $2.49 | $0.37 | 17.45% | 44.9K | $57M | $1.28$2.94 |
| AFJK | Aimei Health Technology | $94.50 | $11.92 | 14.43% | 348.4K | $506M | $6.75$130.37 |
Related Articles
Featured Article
2 Under-the-Radar Stocks to Buy Heading Into 2026
Prosper Junior Bakiny|Dec 1, 2025
These drugmakers are poised to profit from their innovative engines.
Should You Invest in This Under-the-Radar Weight Loss Stock?
Prosper Junior Bakiny|Nov 30, 2025
This small-cap drugmaker just soared on positive clinical trial data, but should you jump on the bandwagon?
Prediction: These 2 Under-the-Radar Stocks Could Beat the Market in the Next 5 Years
Prosper Junior Bakiny|Sep 30, 2025
Both should have significant catalysts by the end of the decade.
Advertisement
3 Bargain Stocks to Buy in a Market That's Priced for Perfection
Yes, bargains can still be found in the stock market.
1 Under-the-Radar Biotech Stock to Buy and Hold
Prosper Junior Bakiny|Sep 29, 2024
It could be an industry giant in the making.
Should You Buy This Sinking Stock on the Dip?
Prosper Junior Bakiny|Jun 27, 2024
The biotech isn't having the best year.
Prediction: These 2 Growth Stocks Could Triple By 2030
Prosper Junior Bakiny|May 11, 2024
These companies have a habit of silencing the bears.
Buying These Dirt-Cheap Stocks Could Be a Brilliant Move
The price could be right for these three biopharma stocks.
These 3 Stocks Have Underperformed the Market This Year. Is Now the Time to Buy?
Sushree Mohanty|Aug 24, 2023
Today's market loser could be tomorrow's market winner.
